Phase
Condition
Diabetes And Hypertension
Diabetes Prevention
Treatment
Metformin or insulin treatment
Clinical Study ID
Ages 18-80 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Signed informed content obtained prior to treatment
Age ≥ 18 years and ≤ 80 years
Eastern Cooperative Oncology Group (ECOG) performance status 0-2
Patients must have histologically confirmed pancreatic adenocarcinoma
History of diabetes mellitus, or newly diagnosed diabetes mellitus according to theAmerican Diabetes Association criteria
The expected survival after surgery ≥ 3 months
Exclusion
Exclusion Criteria:
Active second primary malignancy or history of second primary malignancy
Patients who have received any form of anti-tumor therapy including surgery,chemotherapy, radiotherapy, interventional chemoembolization, radiofrequencyablation, and molecular targeted therapy
Inflammation of the digestive tract, including pancreatitis, cholecystitis,cholangitis, etc
Pregnant or nursing women
Patients who are unwilling or unable to comply with study procedures
Study Design
Connect with a study center
Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University
Shanghai, Shanghai 200032
ChinaSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.